Chemists' Body Sounds Alarm on AI-Generated Fake Prescriptions to PM Modi
The All India Organisation of Chemists and Druggists has urgently written to Prime Minister Narendra Modi, highlighting what it describes as a "grave threat to public health" stemming from the misuse of artificial intelligence tools. The national body warns that AI platforms are being exploited to create fabricated medical prescriptions, allowing individuals to illegally procure restricted medicines with minimal oversight.
Exposure of AI Prescription Fraud
This decisive move follows investigative reports that revealed how AI technology can generate counterfeit prescriptions to purchase antibiotics, psychotropic drugs, and other controlled substances. The organization alleges that certain online platforms are accepting these fraudulent documents, facilitating the unlawful sale of opioids, Schedule H and Schedule X medicines, and even banned drugs.
"AI-generated prescriptions, often featuring fabricated hospital names and details, are being used to systematically bypass established safeguards," the letter states. This practice undermines the integrity of prescription verification processes designed to protect patients.
Regulatory Loopholes in E-Pharmacy Operations
The chemists' body argues that illegal and unregulated e-pharmacy platforms are exploiting regulatory notifications GSR 817(E) and GSR 220(E) issued under the Drugs and Cosmetics Act. These notifications relate to the regulation of online medicine sales and home delivery. The organization claims these platforms misuse the provisions as loopholes to justify online medicine sales without effective prescription verification or accountability.
According to the letter, on digital platforms, it is "practically impossible" to distinguish between genuine prescriptions and AI-generated fake documents. In contrast, offline chemists maintain crucial human oversight through physical verification, direct patient interaction, and the discretion to refuse dispensing when authenticity is questionable.
Serious Public Health Implications
The absence of such safeguards in online dispensing poses significant risks, particularly concerning antimicrobial resistance and the misuse of psychotropic drugs. The organization warns that unchecked access to antibiotics through fake prescriptions could accelerate drug-resistant infections, while easy availability of psychotropic substances could lead to addiction and mental health crises.
Demands for Immediate Regulatory Action
The All India Organisation of Chemists and Druggists has presented a comprehensive list of demands to address this emerging crisis:
- Immediate withdrawal of GSR 817(E) and GSR 220(E) notifications
- Shutdown of illegal and unregulated e-pharmacy platforms by blocking their websites and digital payment gateways
- Prohibition of AI or any digital tools for generating medical prescriptions
- Declaration of AI-generated prescriptions as illegal and invalid nationwide
- Assurance that law-abiding offline chemists are not penalized for technological frauds beyond their control
Leadership Perspective on the Crisis
Rajiv Singhal, General Secretary of the organization, explained that their intervention was prompted by the regulatory vacuum exposed in recent investigations. "The misuse of AI-generated prescriptions, combined with unregulated online dispensing, can seriously compromise patient safety and undermine the integrity of India's drug regulatory system. Strong and immediate regulatory action is essential," Singhal emphasized.
Mounting Pressure on Drug Regulators
This development has significantly increased pressure on regulatory authorities to address emerging risks posed by new technologies in drug dispensing. The debate over oversight of e-pharmacies and digital health platforms has intensified as stakeholders recognize the urgent need to balance technological innovation with robust patient safety measures.
The chemists' warning comes at a critical juncture when digital health platforms are expanding rapidly across India. The organization's letter to the Prime Minister represents a formal escalation of concerns that have been building within the pharmaceutical retail sector about the potential for technology-enabled prescription fraud.
As artificial intelligence becomes more sophisticated and accessible, regulatory frameworks must evolve to prevent its misuse in healthcare. The current situation highlights the tension between technological advancement and traditional safety protocols in medicine distribution, with public health hanging in the balance.
